Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease

European Journal of Neurology

Volumn 17, Issue 5, 2010, Pages 760-762

  Infante, J ^a   Garcia Gorostiaga I ^a   Sanchez Juan P ^a   Sierra, M ^a   Martin Gurpegui J L ^b   Terrazas, J ^c   Mateo, I ^a   Rodriguez Rodriguez E ^a   Berciano, J ^a   Combarros, O ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c Laredo Hospital   (Spain)

Author keywords

Glycogen synthase kinase 3 ; Heme oxygenase 1; Oxidative stress; Parkinson's disease

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT;

EID: 77950874152     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02908.x     Document Type: Article

References (15)

1. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 2008 1147 : 93 104.
2. Chen K, Gunter K, Maines MD. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 2000 75 : 304 313. (Pubitemid 30418197)
3. Benvenisti-Zarom L, Regan RF. Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiol Dis 2007 26 : 688 695. (Pubitemid 46766635)
4. Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 2009 110 : 469 485.
5. Rojo AI, Sagarra MR, Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 2008 105 : 192 202. (Pubitemid 351441636)
6. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004 37 : 1097 1104. (Pubitemid 39296737)
7. García-Gorostiaga I, Sánchez-Juan P, Mateo I, et al. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases. Ann Neurol 2009 65 : 759 761.
8. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm 1993 39 : 165 172.
9. Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium- induced neurotoxicity. Mol Pharmacol 2008 74 : 1564 1575.
10. Funke C, Tomiuk J, Riess O, Berg D, Soehn AS. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson′s disease patients. J Neural Transm 2009 116 : 853 859.
11. Ono K, Goto Y, Takagi S, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004 173 : 315 319. (Pubitemid 38469802)
12. Lee KY, Koh SH, Noh MY, Park KW, Lee YJ, Kim SH. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells. Brain Res 2007 1129 : 89 99.
13. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses Via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007 47 : 89 116. (Pubitemid 46272125)
14. Schäfer M, Goodenough S, Moosmann B, Behl C. Inhibition of glycogen synthase kinase 3β is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res 2004 1005 : 84 89. (Pubitemid 38388403)
15. Kwok JB, Hallupp M, Loy CT, et al. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 2005 58 : 829 839. (Pubitemid 41746872)